Find information about health and nutrition from various and reliable sources all over the world, in just one site. World's latest headlines all in one place.
Wednesday, January 31, 2018
Trying to keep Super Bowl fans healthy during a deadly flu season
From: http://www.cbsnews.com/video/trying-to-keep-super-bowl-fans-healthy-during-a-deadly-flu-season/
Super Bowl fans could be tackled by the flu
From: http://www.cbsnews.com/news/super-bowl-minneapolis-patriots-eagles-fans-could-be-tackled-by-the-flu/
From Diagnosis to Camp: The Mihelich Family’s Story
March 18, 1990 was a night that Randy Mihelich would never forget. That night, he was brought to Elmhurst Hospital by his parents, and subsequently learned that his blood glucose was 1,029, far exceeding the average range. Randy was diagnosed with type 1 diabetes that evening, changing the course of his life forever. He knew that diabetes wasn’t a disease he’d ever be able to “turn off,” but he courageously chugged forward, eventually learning how to better accept and manage the physical and emotional trappings of type 1 diabetes through Association camp programs.
Randy met his wife, Katie, in college. She’s been fully supportive of his diabetes since they met, carrying extra glucose tabs, holding onto his insulin and shots and describing their dating experience as “nothing out of the ordinary.” However, her perspective on diabetes care completely changed when their eldest daughter, Ava, was diagnosed in 2013 at age four. Both Randy and Katie’s hearts sank when they heard the news, but Ava—the spirited, bundle of energy she is—remained optimistic. She had her father as a diabetes role model, and her mother as an exemplary foundation of care.
Randy’s immediate plan upon Ava’s diagnosis was to send her to one of our camp programs. For him, camp was an enlightening experience that welcomed an entirely new network of kids into his life—kids who were “just like him,” dealing with the everyday challenges of managing diabetes, who would become lifelong friends. He wanted the same for Ava.
At only four years old, Ava followed her father’s footsteps and attended her first camp, where she learned to check her blood glucose, count carbohydrates, independently administer insulin and develop a better understanding of her disease. Most importantly, Ava fostered friendships that will last a lifetime. Molly, Ava’s younger sister, acted as a supportive sidekick, attending camp alongside her and playing a large caregiver role in the family’s everyday diabetes management.
Shortly after Ava’s first camp experience, the Mihelich family began riding in the Chicagoland Tour de Cure, one of our fundraising cycling events. This event raises critical funds for diabetes research, advocacy and programs such as camp. “Team Ava’s Peeps” invites friends, family and fellow campers to ride 10 miles through the beautiful, suburban trails of Chicagoland, all in support of Randy, Ava and the entire diabetes community. In addition to rallying the Mihelich network behind this important cause, Ava also used her story to leverage fundraising on corporate teams. In 2014, she spoke to a room full of Walgreens executives, urging them to support Association programs like camp through events like Tour de Cure.
From multiple generations of camps to Tour de Cure, our programs have bonded the Mihelich Family for more than 25 years, providing hope, tradition and a lifetime of treasured memories. In June 2017, we were proud to honor Randy, Katie, Ava and Molly at the Chicago Father of the Year Awards as the Association’s Chicago Mission Family after they raised over $30,000 during the event’s Fund-A-Mission program. Randy and Ava haven’t been able to “turn off” their diabetes, but they choose to embrace its everyday challenges, in hopes to someday realize our vision: a life free of diabetes and all its burdens.
As a long-time National Sponsor of the American Diabetes Association, Walgreens promotes the importance of physical activity with corporate teams that participate in Step Out: Walk to Stop Diabetes® and Tour de Cure® events across the country, and through our summer camps where youth learn independence and valuable skills needed to live a full and healthy life.
From: American Diabetes Association http://diabetesstopshere.org/2018/01/31/from-diagnosis-to-camp-the-mihelich-familys-story/
"IV lounges" a trendy health fad, but are they safe?
From: http://www.cbsnews.com/news/iv-lounges-health-fad-are-they-safe/
Chinese Scientists Make New Ears for Children
The first-of-its-kind study included children with a defect in one ear called microtia.
From: https://www.webmd.com/children/news/20180131/chinese-scientists-make-new-ears-forchildren?src=RSS_PUBLIC
Flu After 65: Your Doctor May Miss It
Although older adults always get hit hard with flu, doctors are less likely to order a flu test for people 65 and older and may miss diagnosing the flu, new research finds.
From: https://www.webmd.com/cold-and-flu/news/20180131/flu-after-65-your-doctor-may-miss-it?src=RSS_PUBLIC
Smoking habit tough to break for certain Americans
From: http://www.cbsnews.com/news/smoking-habits-tougher-to-break-for-certain-americans/
VA System Failing on Mental Health Care: Report
The congressionally mandated report cites two primary reasons for this gap: The VA does not have sufficient resources, or veterans don't know how to access VA mental health care.
From: https://www.webmd.com/mental-health/news/20180131/va-system-failing-on-mental-health-care-report?src=RSS_PUBLIC
Pharmacist sentenced for deadly meningitis outbreak
From: http://www.cbsnews.com/news/meningitis-outbreak-deaths-pharmacist-glenn-chinn-convicted-sentenced-8-years-in-prison/
FDA cracks down on abuse of anti-diarrhea medication
From: http://www.cbsnews.com/news/fda-cracks-down-on-abuse-of-anti-diarrhea-medication/
Infectious Diseases: How the flu makes us so sick
From: Mayo Clinic https://www.youtube.com/watch?v=ssN_DafAdkg
Mission Impact: Letters from the Presidents
This year, we’re proud to welcome Felicia Hill-Briggs, PhD, ABPP and Jane E. B. Reusch, MD to ADA. As President, Health Care & Education and President, Medicine & Science, respectively, they’ll continue to further our mission and support all people living with and affected by diabetes. Learn how they plan to do this, in their own words:
Letter from the President, Health Care & Education
Felicia Hill-Briggs, PhD, ABPP
I am tremendously honored to serve as the 2018 President of Health Care & Education. This is an era both of great challenge and great opportunity. As a health care professional and a researcher, I, like many of you, have witnessed the astounding evolution of diabetes treatments, devices, educational standards, and models of care delivery on one hand, and the realities of suboptimal access, reach, quality, and affordability on the other. Over my four decades of living with type 1 diabetes, I have also personally observed the inequities in care among population subgroups and the variability in diabetes quality of care among geographic regions and practices. More than ever, ADA is needed to help ensure the health of the population with and at risk for diabetes, its comorbidities, and complications.
A population health perspective provides a unifying lens through which to view the scope of challenge and opportunity for the ADA. Population health improvement strategies expand quality services and education beyond the health care setting through multisector and community partnerships. Population health maps pathways to measurable gains in the next decade and beyond through proactive, coordinated strategies for diabetes management, prevention, and equity.
During my year of presidency, I am leading two primary initiatives focused on ADA’s essential role in advancing health equity in diabetes. In February, we are launching an expert technical review committee on Social Determinants of Health (SDOH). While the importance of SDOH has come into awareness, remedying actions and their impact on diabetes population outcomes are less clear. This scientific review committee will examine the state of the evidence on SDOH interventions and their effect on diabetes outcomes, to inform recommendations for clinical and community care. A second initiative will examine closely the role, capacity, and opportunity for ADA to serve as a national resource for the dissemination of evidence-based, nationally recognized, community-delivered diabetes services. Through partnerships with academic institutions, health care practices, and our professional health care and education members who have contributed the science for these community programs, ADA can lead in ensuring reach of high-quality, community-based educational and supportive services to populations most in need across the nation.
In addition to the new initiatives, I continue to champion recent steps we have taken toward diabetes population health improvement. Here are a few highlights:
In 2017 a joint ADA and Association of Diabetes Educators (AADE) consensus statement entitled, “The Use of Language in Diabetes Care and Education,” was published in Diabetes Care. This important statement addresses the impact of language on the lived experience of people with diabetes, their health care, and outcomes. As outlined in the paper, person-first, strengths-based, empowering language is provided to guide communication and improve quality.
The 2016 Diabetes Care publication of Psychosocial Care for People with Diabetes is the first ADA position statement focused on psychosocial and mental health integration into routine care. Dissemination and education channels for this position statement include an available webcast for providers, and it will be featured during the February 2018 65th Advanced Postgraduate Course. In partnership with the American Psychological Association, ADA continues its training workshops in the care of people with diabetes for psychologists. This formal, continuing education training program is increasing the professional mental/behavioral health workforce available to care for people with diabetes. The AADE is currently developing a mental health practice paper for diabetes educators in partnership with ADA.
With Diabetes INSIDE, ADA brings population-focused consulting services to health care systems and clinical practices. Population health analytics allow these organizations to take a population view of their diabetes patients, the quality of care they receive, and their outcomes. ADA provides the know-how for direct alignment of care and health care professional training with the Standards of Care.
ADA is at the forefront of primary diabetes prevention. As a dissemination partner for the National Diabetes Prevention Program (NDPP) through a grant of more than $7M over the next five years from the Centers for Disease Control and Prevention (CDC), ADA will be able to provide the NDPP to underserved populations in the states of California, Texas and Arizona.
Payers have also aligned with population health priorities described above. For example, the Centers for Medicare & Medicaid Services (CMS) has issued an Equity Plan for Improving Quality in Medicare. This plan outlines priorities and goals for advancing equitable care and outcomes for minority and other underserved Medicare beneficiaries through improved quality of care.
Medicare reimbursement for the NDPP rolls out in 2018. Particularly groundbreaking is the ability for the Medicare Diabetes Prevention Program (MDPP) to be delivered in communities, reaching persons most at-risk where they reside. Community organizations demonstrating CDC requirements and lay persons who are trained and certified as MDPP Lifestyle Coaches will be able to register as MDPP suppliers and receive reimbursement directly, rather than requiring interface with a health care system.
Finally, we will watch for further information regarding CMS’ planned reimbursement for the Collaborative Care Model, which embeds behavioral health care management and psychiatric consultation in primary care.
This year promises to be one of significant ADA advancement in diabetes population health. Our progress, as always, depends on you, our members, who bring the front-line expertise, health care delivery, patient and provider education and training, and dissemination nationally and internationally. Stay tuned!
Sincerely,
Felicia
Letter from the President, Medicine & Science
Jane E. B. Reusch, MD
It is my great pleasure and honor to serve as the 2018 American Diabetes Association President of Medicine & Science. The ADA’s mission, “To prevent and cure diabetes and to improve the lives of all people affected by diabetes,” aligns with my personal and professional mission. As an ADA member, I am confident that the mission speaks to you as well. In this introductory communication, I am going to ask you to consider why you are a member of the ADA and to tell you a bit about why and how I am involved in the ADA. I will highlight some of the current mission activities of the ADA and invite you to reach out to me.
Why are you a member of the ADA? Each of you has a different type of engagement with the diabetes landscape that may involve education, practice, research, or industry relations. As a member of the ADA you are invited (and encouraged) to join interest groups that are aligned with your own professional goals. For the ADA to achieve its mission, it is crucial that each of us join in the fight against diabetes. It is a goal of the ADA to increase your impact day to day to advocate and educate toward the goal of curing this devastating disease.
What is the background that I bring to my role as President of Medicine & Science? I was attracted to the field of diabetes based on the combination of intriguing pathophysiology and as the daughter of a father with diabetes. My father’s diabetes illustrated to me the demands diabetes places on individuals and their families every day and the consequences. For my father, the consequence was a stroke with right-sided paralysis, threatened loss of his functional left leg, and an untimely death. To me, as you can appreciate, diabetes is incredibly personal.
In my work life, I am a physician scientist (AKA “the world’s best job”). As a physician scientist, I have the opportunity to care for people with diabetes, to do research to address the biological consequences of diabetes, and to educate the next generation of scientists and clinicians to address the ADA’s mission. Sincerely, my job is a privilege. Early in my career, I became aware of the challenges facing the physician scientist and the dire need for mentorship to bolster the careers of MD scientists. I have held leadership positions at my own institution and nationally to make resources available for formal career development training, career development funding, and mentoring. I am dedicated to recruiting, training, and retaining outstanding young scientists to the field of diabetes research with a special focus on the physician scientist. In addition to mentoring, effective translational research also requires teamwork, as the skill sets needed to effectively address complex biological questions rarely reside in a single lab or individual.
Similarly, as a leader within the ADA, I believe we will need to employ a model of teamwork and collaboration to change the diabetes landscape. Recently, I had the opportunity to assist in the development of a specific new membership benefit to increase Diabetes Professional Self-Efficacy (DPSE). We recently launched the Women’s Interprofessional Network of the ADA (WIN ADA) as a new ADA membership benefit. This initiative’s goals are simple, yet profound: to strengthen the voice and presence of women in diabetes research and clinical practice; to recognize the significant contributions of women to improving the lives of people affected by diabetes; and to provide development and networking opportunities to women of all career stages and interests to help them achieve their full potential. This is one example of the ADA responding to the needs of our membership.
The ADA is the leading authority for diabetes. We host the ADA Scientific Sessions, the largest diabetes meeting in the world. We publish Diabetes Care and Diabetes, two of the top journals in the world specifically focused on diabetes care and research. We fund innovative research in diabetes, and we provide the most widely disseminated Standards of Care. We support accredited clinical diabetes programs, we advocate for the rights of people with diabetes through programs like Safe at School, and we support research funding commensurate with the burden of diabetes. Plus, perhaps the ADA’s most life-changing activity, we sponsor diabetes camps for more than 6,000 children a year. Camp provides children with the skills and empowerment to take on a lifetime of diabetes. We are a powerful force for our mission.
Still, the challenges that remain to accomplishing the goals of the ADA are many. Currently, more than 30 million Americans and 422 million people worldwide suffer with diabetes, and hundreds of millions more are at risk for developing diabetes. The estimated financial burden of diabetes worldwide is greater than a trillion dollars. Predictions suggest the number of individuals with diabetes will increase to more than 600 million by the year 2040. We need to change this predicted trajectory. We need to decrease not only the number of people with diabetes, but also the burden of diabetes in their lives. In my opinion, the only way to change this unacceptable trajectory is through partnerships and teamwork.
So I ask again, why are you a member of the ADA? I will reframe that question to ask, are you willing and interested in using your skills to prevent and cure diabetes and improve the lives of all people with diabetes? How can the ADA make it possible for you to engage in its programs and to have a real impact? How can the ADA reach out to individuals with diabetes, institutions or organizations dedicated to diabetes, decision-makers for research funding and global economies to get the message out that this is an urgent and deadly disease? If you have ideas, connections, or resources to help fuel this battle, then we need you engaged…we need you to be a partner with the ADA! Please get connected with us.
I am dedicated to addressing the mission of the ADA. I hope to hear from you on how we can improve your DPSE.
With humility and passion,
Jane
From: American Diabetes Association http://diabetesstopshere.org/2018/01/31/mission-impact-letters-from-the-presidents/
'IV Lounges' Are Suddenly Hip, But Are They Safe?
But experts say these lounges are at best a waste of money and at worst potentially dangerous.
From: https://www.webmd.com/a-to-z-guides/news/20180131/iv-lounges-are-suddenly-hip-but-are-they-safe?src=RSS_PUBLIC
Agency finalizes rule on patient records
From: By Jennifer Garvin
https://www.ada.org/en/publications/ada-news/2018-archive/january/agency-finalizes-rule-on-patient-records
Low-Carb Diets Boost Risk of Serious Birth Defects
Researchers have found a link between lack of carbs and serious risk of birth defects.
From: https://www.webmd.com/baby/news/20180130/low-carb-diets-boost-risk-of-serious-birth-defects?src=RSS_PUBLIC
WHO: Syrian Arab Republic - Supporting Health in Camps
From: World Health Organization https://www.youtube.com/watch?v=PVOt2kAzfcg
OMS: Poliovirus dérivés d’une souche vaccinale
From: World Health Organization https://www.youtube.com/watch?v=NRUZiQmUHIM
WHO: فيروس شلل الأطفال المستمد من اللقاح
From: World Health Organization https://www.youtube.com/watch?v=posR3gKCjlA
OMS: Respuesta ante un brote de poliomielitis
From: World Health Organization https://www.youtube.com/watch?v=qKgxcDr4Ht8
WHO: Vaccine-derived polioviruses (subtitled)
From: World Health Organization https://www.youtube.com/watch?v=8KBggvFhKh8
OMS: O Sistema de Vigilância da Poliomielite
From: World Health Organization https://www.youtube.com/watch?v=Mw1MsYZYG88
OMS: El sistema de vigilancia de la poliomielitis
From: World Health Organization https://www.youtube.com/watch?v=ZquMmJexPmU
CDC director resigns after report about tobacco stock trading
From: http://www.cbsnews.com/news/brenda-fitzgerald-cdc-director-resigns-report-tobacco-stock-trading/
WHO: Vaccine-derived polioviruses
From: World Health Organization https://www.youtube.com/watch?v=CZxqz4bX048
OMS: Alcançando a todos em qualquer lugar
From: World Health Organization https://www.youtube.com/watch?v=014piVTpp9U
OMS: Polio - Llegar a todos los niños
From: World Health Organization https://www.youtube.com/watch?v=bU96xX2fZS8
Mayo Clinic Minute: The problem with parents over-pressuring kids to win
From: Mayo Clinic https://www.youtube.com/watch?v=HmHUTxSSFAE
OMS: Respondendo a um surto de poliomielite
From: World Health Organization https://www.youtube.com/watch?v=nY5i3jeqeo4
Newer drugs are improving survival for men with metastatic prostate cancer
Treatments for advanced prostate cancer that’s metastasizing, or spreading in the body, are getting better, and men with the disease are living longer because of them, new research has found.
For years, the only available treatments for these aggressive tumors were androgen-deprivation therapies (ADT) that block testosterone, the male sex hormone that makes prostate cancer cells grow faster. Giving ADT slows cancer progression, but tumors typically develop resistance against it within three years and start growing again.
But then newer treatments for metastatic prostate cancer started showing up. A drug called docetaxel was approved by the FDA in 2004, followed by cabazitaxel in 2010, sipuleucel-T in 2011, abiraterone in 2011, and enzalutamide in 2012. Each of these drugs targets metastatic prostate cancer in different ways, and men who took any one of them in clinical trials lived longer than men who took ADT by itself.
For the current study, researchers set out to answer a unique question. They wanted to know if the combined market availability of these drugs was making a survival difference for men being treated for metastatic prostate cancer in the general population.
To find out, they divided men tracked by a national cancer registry into two groups. One group of 4,298 men had been diagnosed with metastatic prostate cancer between 2004 and 2008, and another equally sized group was diagnosed with the disease between 2009 and 2014. All the men in both groups were matched in terms of age, race, cancer stage at diagnosis, treatment, and other factors.
Results showed that the duration of survival before men died specifically from prostate cancer lasted approximately 32 months among those diagnosed during the earlier time frame, and 36 months among those diagnosed during the later one. Similarly, the duration of survival before men died from any cause after a metastatic prostate cancer diagnosis was 26 months between 2004 and 2008, and 29 months during the 2009–2014 time frame.
The authors acknowledge that the survival improvements are modest, but add they may not fully account for longer survival improvements from abiraterone and enzalutamide, which only came into widespread use at the end of the study period. Furthermore, men who respond extraordinarily well to the new treatments may live far longer than those who don’t. In general, the evidence provides “valid evidence in support of [newer] novel treatments,” the authors wrote.
Dr. Mark Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, and editor in chief of HarvardProstateKnowledge.org, says, “This study provides important information that men with advanced forms of prostate cancer are now living longer than they once did, sometimes years longer. Those of us who have been treating prostate cancer for decades appreciate this study’s fundamental finding that the improved longevity from newer cancer drugs is considerable.”
The post Newer drugs are improving survival for men with metastatic prostate cancer appeared first on Harvard Health Blog.
From: Charlie Schmidt https://www.health.harvard.edu/blog/newer-drugs-metastatic-prostate-cancer-2018013113196
ADA Foundation announces three Give Kids A Smile grant recipients
From: https://www.ada.org/en/publications/ada-news/2018-archive/january/ada-foundation-announces-three-give-kids-a-smile-grant-recipients
Study: Dental benefits can help employers improve workforce, their bottom line
From: By David Burger
https://www.ada.org/en/publications/ada-news/2018-archive/january/study-dental-benefits-can-help-employers-improve-workforce-their-bottom-line
Working too long can be unhealthy -- and fatal
From: http://www.cbsnews.com/news/working-too-long-can-unhealthy-and-fatal/
WHO: Saving lives through RAcE in Nigeria
From: World Health Organization https://www.youtube.com/watch?v=mvXbZjafu_0
Opioid Crisis Leads FDA To Restrict Imodium
Because opioid abusers are using the drug in greater numbers, the FDA is requesting that makers "change the way they label and package these drugs, to stem abuse and misuse," Gottlieb said.
From: https://www.webmd.com/digestive-disorders/news/20180130/opioid-crisis-leads-fda-to-restrict-imodium?src=RSS_PUBLIC
Working too long can be unhealthy -- and fatal
From: http://www.cbsnews.com/news/working-too-long-can-unhealthy-and-fatal/
WHO: Saving lives through RAcE in Nigeria
From: World Health Organization https://www.youtube.com/watch?v=mvXbZjafu_0